Past Speakers

Mitra Tavakkoli, MD, PharmD

VP of clinical development and Head of Drug Safety
Sangamo Therapeutics
USA

Arun Srivastava

Professor
University of Florida College of Medicine
USA

Jeff Chaffin

Market Access Strategy and Contracting Consultant
Miles Payer Strategy
USA

Hildegund Ertl

Professor
The Wistar Institute
USA

Rachel Legmann

Senior Director of Technology, GCT & & Thought Leader
Repligen Corporation
USA

Sophie Blondel

Founder and CEO
Fox-Bio
France

Deyaa Shaheen

Founder
XFDA PHARMA ADVISORS CONSULTANTING SERVICES
USA

Curtis Kugel

Manager, ZS
USA

Rajiv Gangurde

Director
Vice President, Technical Operations, Cell & Gene Therapy
Parexel
USA

Anis Khimani, Ph.D.,

Senior Manager
Global Product Management,
Antylia Scientific
USA

Andrew Steinsapir

Director, Gene Therapy Program Lead
Deerfield Discovery and Development
USA

Mehmet Karaca
(Poster Presentation)

Director
Molecular Biology-Sequencing
Sarepta Therapeutics
USA

Chris A. Learn

Senior Vice President
Cell and Gene Therapy Center of Excellence
Parexel
USA

Daya Verma

(Panel Discussion)

Former Director
Program and Portfolio Management
Novartis Pharmaceuticals Corporation
USA

Amanda Moore

CEO
Angelman Syndrome Foundation
USA

Kok-Seong Lim

Independent Consultant
USA

Volney L. Sheen, MD, PhD

Associate Professor of Neurology,
Harvard Medical School
USA

Melissa Penn
(Panel Discussion)

Bayer Pharmaceuticals
USA

​Daniel C. Chung

Chief Medical Officer
Beacon Therapeutics
USA

Molly S. McGlaughlin

Chief Executive Officer
Revolution Biomanufacturing Inc
USA

Devyn Smith

Chief Executive Officer
Arbor Biotechnologies
USA

Alonza Cruse

Ex-FDA
Director, Office of Pharmaceutical Quality Operations
USA

Nermin Ibreljic

 Principal Engineer, Gene Therapy
Sarepta Therapeutics
USA

Rachel Smith

Vice President
Rare and Genetic Disease
 Parexel
UK

Patrick Starremans
(Panel Discussion)

Head of Analytical Sciences
Solid Biosciences Inc.
USA

Emily Moran

Founder
Vector Biolabs
USA

José Vázquez
(Poster Presentation)

Key Account Manager
c-LEcta GmbH
Germany

Mihir N. Shukla

𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗖𝗘𝗢
Biopharma Consulting Solutions, LLC
USA

Daozhan Yu

President and CEO
AAVnerGene Inc.
USA

Celia Goeldner
(Delegate)

Clinical Expert Team Leader
Roche.
USA

Wai Lydia Tai, PhD

Schepens Eye Research Institute of Massachusetts Eye and Ear ,Department of Ophthalmology
Harvard Medical School.
USA

Larry Forman

Founder and CEO
CHO Plus, Inc
USA

Jeremy Shelley

Director of Business Development
Form Bio
USA

Brian Tomkowicz, PhD

Vice-President, Head of R&D & Virology Fellow
SK pharmteco
USA

Greg Hermetet
(Delegate)

Executive Director
SK pharmteco
USA

Z. GAO

COO, CoFounder
Uni-Pioneers Bio-Med, Inc

Michael DiBiasio-White
(Panel discussion)

Founder-Principal Consultant
ViroSpark BioConsulting
USA

Bhushan Surve
(Delegate )

Sr. Global Director Business Development & Head of Marketing
CoJourney
USA

David Greenwald
(Panel disussion )

Managing Director
Deerfield Management
USA

Abby Ye
(Delegate)

Business Development Manager
ProBio
USA

Anita Mardian

Vice President,Unit Head
Parexel
USA

Nagendra Chemuturi

Senior Director
Eli Lilly and Company
USA

Grace (Qing) Lan
(Delegate)

Director of Biopharmaceutical Services
Primera Analytical Solutions Corporation
USA

Christian Schwabe
(Delegate)

Executive Director
NZCR
USA

Evan Hutt
(Delegate)

Graduate Research Fellow
Rowan University
USA

Anne Douar

Chief Operating Officer, Vivet Therapeutics, France

Binh Nyugen

President, WYNNGATE Corporation, EX-FDA, USA

Cellia Habita

Biotech Senior Executive, Expert in Drug Development & Clinical Development Operations, France

James L Drinkwater

Ex-Chairman Honorary Member of PHSS, Head of GMP Compliance, Franz Ziel GmbH, United Kingdom

Natasha Paterson

Executive Director Medical Affairs, Tenaya Therapeutics, USA

Olivier Negre

Chief Scientific Officer, Smart Immune, France

Tristan Jervis

Founder and Managing Director, Impact Shine Communications, UK

Paul Thomas

Director of South Australian Genome Editing (SAGE) Facility, Adelaide, Australia

Gabriela Brumatti

Senior Scientist,
Cell & Gene Therapy, CSL, Victoria, Australia

John Rasko

Head of Dept, Royal Prince Alfred Hospital. Prof, The Univ. of Sydney. Head, Gene and Stem Cell Therapy Program, Centenary Inst., Australia

Omar Dabbous

VP, Global Geneconomics and Outcomes Research, Gene Therapy, Novartis  Illinois, US

Michelle Farrar

Associate Professor, School of Women's and Children's Health, University of New South Wales, Australia

Ryuichi Morishita

Professor of Department of Clinical Gene Therapy, Center of Medical, Innovation and Translational, Research School of Medicine, Osaka University, Japan

Hinda Daggag

Corporate Genetic Project Head, Corporate Medical and Clinical Affairs, Abu Dhabi Health Services Co. - SEHA, UAE

Albert Garcia Minambres

Senior Scientist, Assay Development Group, CSL, Victoria, Australia

Wei Deng

Associate Professor, School of Biomedical Engineering
University of Technology Sydney, Australia

Marxa Figueiredo

Associate Professor, Department of Basic Medical Sciences, Purdue University College of Veterinary Medicine, USA

Ernst Wagner

Chair, Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität(LMU) München, Germany

Sharon Sagnella

Research and Development Manager, Cell & Molecular Therapies, Royal Prince Alfred Hospital, Australia

Chul-Su Yang, Ph.D.

Professor, Dept. of Molecular & Life Science, Hanyang University ERICA, Ansan 15588, S. Korea

Marina Rajic

Founder & CEO, BioViros Limited, Wellington, New Zealand

Adi Idris

Research Fellow, Griffith Centre for Cell and Gene Therapy, Menzies Health Institute Queensland, Australia

Adam Tilley

Scientist, CSL
Victoria, Australia

Loraine Tung

Research Associate
University of Cambridge, UK